- Home
- FHTX vs KGEI Comparison
FHTX vs KGEI Comparison
Compare FHTX & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- KGEI
- Stock Information
- Founded
- FHTX 2015
- KGEI 2008
- Country
- FHTX United States
- KGEI United States
- Employees
- FHTX N/A
- KGEI N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- KGEI
- Sector
- FHTX Health Care
- KGEI
- Exchange
- FHTX Nasdaq
- KGEI Nasdaq
- Market Cap
- FHTX 278.1M
- KGEI 254.9M
- IPO Year
- FHTX 2020
- KGEI N/A
- Fundamental
- Price
- FHTX $4.89
- KGEI $6.16
- Analyst Decision
- FHTX Strong Buy
- KGEI Strong Buy
- Analyst Count
- FHTX 8
- KGEI 1
- Target Price
- FHTX $12.63
- KGEI $11.00
- AVG Volume (30 Days)
- FHTX 118.7K
- KGEI 149.4K
- Earning Date
- FHTX 08-05-2025
- KGEI 08-11-2025
- Dividend Yield
- FHTX N/A
- KGEI N/A
- EPS Growth
- FHTX N/A
- KGEI 42.32
- EPS
- FHTX N/A
- KGEI 0.57
- Revenue
- FHTX $24,173,000.00
- KGEI $60,739,000.00
- Revenue This Year
- FHTX $33.60
- KGEI $19.44
- Revenue Next Year
- FHTX $5.87
- KGEI $38.49
- P/E Ratio
- FHTX N/A
- KGEI $10.54
- Revenue Growth
- FHTX N/A
- KGEI 20.06
- 52 Week Low
- FHTX $2.95
- KGEI $2.85
- 52 Week High
- FHTX $10.25
- KGEI $9.89
- Technical
- Relative Strength Index (RSI)
- FHTX 42.08
- KGEI 49.20
- Support Level
- FHTX $4.72
- KGEI $5.70
- Resistance Level
- FHTX $5.24
- KGEI $6.18
- Average True Range (ATR)
- FHTX 0.41
- KGEI 0.23
- MACD
- FHTX -0.16
- KGEI 0.03
- Stochastic Oscillator
- FHTX 13.73
- KGEI 61.43
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.